Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
Harriet L. Robinson(GeoVax (United States)), Harold M. McClure, Rhona L. Glickman(New England Biolabs (United States)), Shari L. Lydy, Tahir A. Rizvi(The University of Texas MD Anderson Cancer Center), David C. Montefiori(Duke Medical Center), Jeffrey D. Lifson(Science Applications International Corporation (United States)), Shiu-Lok Hu(University of Washington), Maria Angelito Candido, James G. Herndon, Dennis Panicali(Fox Chase Cancer Center), Gail P. Mazzara(Rogers (United States)), Shan Lü(University of Massachusetts Chan Medical School), Marcia L. Kalish(Centers for Disease Control and Prevention), Michael S. Wyand(Dana-Farber Cancer Institute), Kelledy Manson(Dana-Farber Cancer Institute), R. Paul Johnson(Emory University)
Cited by 381
Related Papers
Importance of the nef gene for maintenance of high virus loads and for development of AIDS
|Cell|1991|1.6k
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2010|975
High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors
|Journal of Virology|1995|513
Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.
|Proceedings of the National Academy of Sciences|1982|503
Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity
|The Journal of Immunology|2004|384